Wakeman Brian S, Izumiya Yoshihiro, Speck Samuel H
Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Dermatology, University of California Davis School of Medicine, Sacramento, California, USA.
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01434-16. Print 2017 Jan 1.
Kaposi's sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus that has been associated with primary effusion lymphoma and multicentric Castleman's disease, as well as its namesake Kaposi's sarcoma. As a gammaherpesvirus, KSHV is able to acutely replicate, enter latency, and reactivate from this latent state. A key protein involved in both acute replication and reactivation from latency is the replication and transcriptional activator (RTA) encoded by the gene Orf50 RTA is a known transactivator of multiple viral genes, allowing it to control the switch between latency and virus replication. We report here the identification of six alternatively spliced Orf50 transcripts that are generated from four distinct promoters. These newly identified promoters are shown to be transcriptionally active in 293T (embryonic kidney), Vero (African-green monkey kidney epithelial), 3T12 (mouse fibroblast), and RAW 264.7 (mouse macrophage) cell lines. Notably, the newly identified Orf50 transcripts are predicted to encode four different isoforms of the RTA which differ by 6 to 10 residues at the amino terminus of the protein. We show the global viral transactivation potential of all four RTA isoforms and demonstrate that all isoforms can transcriptionally activate an array of KSHV promoters to various levels. The pattern of transcriptional activation appears to support a transcriptional interference model within the Orf50 region, where silencing of previously expressed isoforms by transcription initiation from upstream Orf50 promoters has the potential to modulate the pattern of viral gene activation.
Gammaherpesviruses are associated with the development of lymphomas and lymphoproliferative diseases, as well as several other types of cancer. The human gammaherpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV), is tightly associated with the development of Kaposi's sarcoma and multicentric Castleman's disease, as well as a rare form of B cell lymphoma (primary effusion lymphoma) primarily observed in HIV-infected individuals. RTA is an essential viral gene product involved in the initiation of gammaherpesvirus replication and is conserved among all known gammaherpesviruses. We show here for KSHV that transcription of the gene encoding RTA is complex and leads to the expression of several isoforms of RTA with distinct functions. This observed complexity in KSHV RTA expression and function likely plays a critical role in the regulation of downstream viral and cellular gene expression, leading to the efficient production of mature virions.
卡波西肉瘤相关疱疹病毒(KSHV)是一种γ疱疹病毒,与原发性渗出性淋巴瘤、多中心Castleman病及其同名的卡波西肉瘤有关。作为一种γ疱疹病毒,KSHV能够急性复制、进入潜伏期并从这种潜伏状态重新激活。参与急性复制和从潜伏期重新激活的关键蛋白是由基因Orf50编码的复制和转录激活因子(RTA)。RTA是多种病毒基因的已知反式激活因子,使其能够控制潜伏期和病毒复制之间的转换。我们在此报告了从四个不同启动子产生的六种选择性剪接的Orf50转录本的鉴定。这些新鉴定的启动子在293T(胚胎肾)、Vero(非洲绿猴肾上皮)、3T12(小鼠成纤维细胞)和RAW 264.7(小鼠巨噬细胞)细胞系中显示具有转录活性。值得注意的是,新鉴定的Orf50转录本预计编码RTA的四种不同异构体,它们在蛋白质的氨基末端相差6至10个残基。我们展示了所有四种RTA异构体的整体病毒反式激活潜力,并证明所有异构体都能在不同水平上转录激活一系列KSHV启动子。转录激活模式似乎支持Orf50区域内的转录干扰模型,即上游Orf50启动子的转录起始对先前表达的异构体进行沉默有可能调节病毒基因激活模式。
γ疱疹病毒与淋巴瘤和淋巴增殖性疾病以及其他几种癌症的发生有关。人类γ疱疹病毒,卡波西肉瘤相关疱疹病毒(KSHV),与卡波西肉瘤和多中心Castleman病的发生密切相关,以及一种主要在HIV感染个体中观察到的罕见B细胞淋巴瘤(原发性渗出性淋巴瘤)。RTA是参与γ疱疹病毒复制起始的必需病毒基因产物,在所有已知的γ疱疹病毒中保守。我们在此表明,对于KSHV,编码RTA的基因转录是复杂的,并导致具有不同功能的几种RTA异构体的表达。在KSHV RTA表达和功能中观察到的这种复杂性可能在下游病毒和细胞基因表达的调节中起关键作用,从而导致成熟病毒体的有效产生。